MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-14-2023
Zynerba Pharmaceuticals P/B Ratio 2011-2026 | ZYNE
Annual P/B Ratio Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.406 | 1.44 | 1.57 | 1.47 | 1.34 | 2.63 | 5.21 | 0.743 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.21 | 0.406 | 1.85 |
P/B Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
2.2 | - | - | $ 142 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
-18.8 | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
0.291 | $ 1.14 | -1.73 % | $ 123 M |  Canada |
 |
Cronos Group
CRON
|
2.12 | $ 2.63 | - | $ 1.38 B | Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
2.78 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-27.6 | - | 0.86 % | $ 117 M | USA |
 |
Catalent
CTLT
|
3.01 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
-0.0793 | - | 10.11 % | $ 58.2 M | USA |
 |
Aurora Cannabis
ACB
|
0.449 | $ 4.19 | -1.64 % | $ 86.3 M | Canada |
 |
DURECT Corporation
DRRX
|
0.703 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.46 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
0.0133 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-0.868 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
0.662 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
0.122 | - | 2.45 % | $ 38.1 M | Canada |
 |
Emergent BioSolutions
EBS
|
0.214 | $ 12.39 | 1.98 % | $ 634 M | USA |
 |
Athenex
ATNX
|
-0.473 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
9.71 | $ 21.56 | 0.07 % | $ 2.05 B |  France |
 |
Evolus
EOLS
|
161 | $ 6.67 | -0.07 % | $ 414 M | USA |
 |
Harrow Health
HROW
|
4.93 | $ 49.34 | -1.36 % | $ 1.61 B | USA |
 |
China Pharma Holdings
CPHI
|
0.586 | $ 1.22 | -8.65 % | $ 21.3 M |  China |
 |
OrganiGram Holdings
OGI
|
0.795 | $ 1.69 | -0.88 % | $ 402 M | Canada |
 |
Bausch Health Companies
BHC
|
-41.3 | $ 6.96 | -0.43 % | $ 2.54 B | Canada |
 |
Lannett Company
LCI
|
-1.43 | - | 1.15 % | $ 7.11 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
0.00923 | - | - | $ 193 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
3.93 | $ 3.96 | -0.13 % | $ 55.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
1.08 | $ 5.14 | -0.77 % | $ 677 M | USA |
 |
Sundial Growers
SNDL
|
0.000669 | $ 1.64 | -0.61 % | $ 3.37 M | Canada |
 |
Pacira BioSciences
PCRX
|
1.51 | $ 26.04 | -0.12 % | $ 1.2 B | USA |
 |
PetIQ
PETQ
|
0.456 | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
-38.1 | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
0.916 | $ 13.91 | -0.22 % | $ 1.91 B | USA |
 |
ProPhase Labs
PRPH
|
2.05 | $ 0.44 | -2.36 % | $ 6.97 M | USA |
 |
Rockwell Medical
RMTI
|
1.67 | $ 0.81 | -0.96 % | $ 18.9 M | USA |
 |
Radius Health
RDUS
|
-1.5 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
2.27 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
1.89 | $ 4.79 | 5.63 % | $ 144 M | USA |
 |
OptiNose
OPTN
|
-2.21 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
0.479 | $ 9.08 | -1.3 % | $ 645 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
0.83 | $ 3.54 | -2.13 % | $ 4.39 M | USA |
 |
PLx Pharma
PLXP
|
2.29 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
1.64 | $ 5.76 | 0.96 % | $ 235 M | USA |
 |
SCYNEXIS
SCYX
|
0.964 | $ 0.63 | 3.22 % | $ 30.1 M | USA |
 |
Tricida
TCDA
|
1.65 K | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
0.358 | $ 8.97 | -0.54 % | $ 5.54 B | Canada |
 |
Veru
VERU
|
3.34 | $ 2.13 | -1.84 % | $ 287 M | USA |
 |
TherapeuticsMD
TXMD
|
0.816 | $ 1.63 | -0.61 % | $ 17 M | USA |
 |
Viatris
VTRS
|
0.646 | $ 12.52 | -0.2 % | $ 15.2 B | USA |
 |
cbdMD
YCBD
|
0.857 | $ 1.37 | 0.37 % | $ 5.91 M | USA |